Stryker Corporation (NYSE:SYK) Shares Sold by Cohen Capital Management Inc.

Cohen Capital Management Inc. reduced its position in Stryker Corporation (NYSE:SYK) by 1.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 83,114 shares of the medical technology company’s stock after selling 1,600 shares during the quarter. Stryker makes up 5.3% of Cohen Capital Management Inc.’s portfolio, making the stock its largest holding. Cohen Capital Management Inc.’s holdings in Stryker were worth $30,939,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Capital A Wealth Management LLC acquired a new stake in Stryker in the 4th quarter valued at $26,000. Goodman Advisory Group LLC bought a new position in shares of Stryker during the first quarter valued at $32,000. City Holding Co. boosted its stake in shares of Stryker by 528.6% in the 1st quarter. City Holding Co. now owns 88 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 74 shares in the last quarter. VSM Wealth Advisory LLC bought a new stake in shares of Stryker in the 4th quarter worth about $36,000. Finally, Smallwood Wealth Investment Management LLC acquired a new stake in shares of Stryker during the 1st quarter worth about $40,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on SYK shares. BTIG Research set a $403.00 price target on shares of Stryker and gave the company a “buy” rating in a research report on Monday, April 14th. Needham & Company LLC reissued a “buy” rating and set a $442.00 price target on shares of Stryker in a research note on Friday, March 21st. Sanford C. Bernstein set a $450.00 price objective on shares of Stryker in a research report on Monday, May 5th. Evercore ISI increased their price objective on Stryker from $390.00 to $415.00 and gave the company an “outperform” rating in a research report on Tuesday, July 8th. Finally, Truist Financial lifted their target price on Stryker from $390.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, May 5th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $428.55.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the transaction, the director directly owned 3,417,326 shares of the company’s stock, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.20% of the stock is owned by corporate insiders.

Stryker Trading Down 1.4%

SYK opened at $389.24 on Monday. Stryker Corporation has a twelve month low of $314.93 and a twelve month high of $406.19. The firm has a market cap of $148.57 billion, a PE ratio of 52.60, a price-to-earnings-growth ratio of 2.94 and a beta of 0.91. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. The firm’s fifty day moving average is $384.79 and its two-hundred day moving average is $377.20.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating the consensus estimate of $2.73 by $0.11. The business had revenue of $5.87 billion for the quarter, compared to analysts’ expectations of $5.68 billion. Stryker had a return on equity of 23.74% and a net margin of 12.31%. Stryker’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.50 EPS. Equities research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Monday, June 30th. Stryker’s dividend payout ratio is 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.